EA201490233A8 - Стабильные лекарственные формы артеролана и пиперахина - Google Patents
Стабильные лекарственные формы артеролана и пиперахинаInfo
- Publication number
- EA201490233A8 EA201490233A8 EA201490233A EA201490233A EA201490233A8 EA 201490233 A8 EA201490233 A8 EA 201490233A8 EA 201490233 A EA201490233 A EA 201490233A EA 201490233 A EA201490233 A EA 201490233A EA 201490233 A8 EA201490233 A8 EA 201490233A8
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- piperahin
- arterolana
- medical forms
- stable medical
- stable
- Prior art date
Links
- 239000003430 antimalarial agent Substances 0.000 abstract 1
- 229940033495 antimalarials Drugs 0.000 abstract 1
- 239000006186 oral dosage form Substances 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/183,119 US8664265B2 (en) | 2005-05-18 | 2011-07-14 | Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials |
| IN2703DE2011 | 2011-09-19 | ||
| IN2156DE2012 | 2012-07-12 | ||
| PCT/IB2012/053614 WO2013008218A1 (fr) | 2011-07-14 | 2012-07-13 | Formes posologiques stables d'artérolane et de pipéraquine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA201490233A1 EA201490233A1 (ru) | 2014-07-30 |
| EA201490233A8 true EA201490233A8 (ru) | 2015-01-30 |
Family
ID=47505579
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201490233A EA201490233A8 (ru) | 2011-07-14 | 2012-07-13 | Стабильные лекарственные формы артеролана и пиперахина |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP2731603A1 (fr) |
| JP (1) | JP2014522856A (fr) |
| KR (1) | KR20140053169A (fr) |
| CN (1) | CN103930107A (fr) |
| AP (1) | AP2014007413A0 (fr) |
| AU (1) | AU2012282077A1 (fr) |
| CA (1) | CA2850089A1 (fr) |
| EA (1) | EA201490233A8 (fr) |
| MX (1) | MX2014000463A (fr) |
| WO (1) | WO2013008218A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014132226A1 (fr) | 2013-02-28 | 2014-09-04 | Ranbaxy Laboratories Limited | Formulation dispersible stable de maléate d'artérolane et de pipéraquine et procédé de préparation de celle-ci |
| KR101698003B1 (ko) * | 2016-06-20 | 2017-01-19 | 여오영 | 퀴닌 염 현탁액을 포함하는 항암 치료를 위한 국소 투여용 주사제 조성물 |
| CA3083683A1 (fr) * | 2017-12-12 | 2019-06-20 | Intervet International B.V. | Compositions pharmaceutiques d'isoxazoline implantable et utilisations correspondantes |
| TW202220645A (zh) * | 2020-08-14 | 2022-06-01 | 印度商太陽製藥工業有限公司 | 用於治療瘧疾的固定劑量組合藥物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6486199B1 (en) | 2001-06-21 | 2002-11-26 | Medicines For Malaria Venture Mmv International Centre Cointrin | Spiro and dispiro 1,2,4-trioxolane antimalarials |
| US6906205B2 (en) | 2002-06-21 | 2005-06-14 | Medicines For Malaria Venture Mmv | Spiro and dispiro 1,2,4-trioxolane antimalarials |
| US6825230B2 (en) | 2002-06-21 | 2004-11-30 | Medicines For Malaria Venture Mmv | Spiro and dispiro 1,2,4-trixolane antimalarials |
| HUE033191T2 (en) * | 2005-05-18 | 2017-11-28 | Sun Pharmaceutical Ind Ltd | Stable dosage forms of spiro and dispiro-1,2,4-trioxolane anti-malarial agents |
| WO2007132438A2 (fr) * | 2006-05-17 | 2007-11-22 | Ranbaxy Laboratories Limited | Traitement antipaludéen faisant appel à une combinaison d'un dérivé d'artémisinine synthétique et d'un dérivé de bisquinoline |
-
2012
- 2012-07-13 EA EA201490233A patent/EA201490233A8/ru unknown
- 2012-07-13 KR KR1020147003043A patent/KR20140053169A/ko not_active Application Discontinuation
- 2012-07-13 EP EP12743776.2A patent/EP2731603A1/fr not_active Withdrawn
- 2012-07-13 CA CA2850089A patent/CA2850089A1/fr not_active Abandoned
- 2012-07-13 AU AU2012282077A patent/AU2012282077A1/en not_active Abandoned
- 2012-07-13 AP AP2014007413A patent/AP2014007413A0/xx unknown
- 2012-07-13 CN CN201280044576.7A patent/CN103930107A/zh active Pending
- 2012-07-13 JP JP2014519689A patent/JP2014522856A/ja active Pending
- 2012-07-13 WO PCT/IB2012/053614 patent/WO2013008218A1/fr active Application Filing
- 2012-07-13 MX MX2014000463A patent/MX2014000463A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN103930107A (zh) | 2014-07-16 |
| CA2850089A1 (fr) | 2013-01-17 |
| MX2014000463A (es) | 2014-07-09 |
| KR20140053169A (ko) | 2014-05-07 |
| EA201490233A1 (ru) | 2014-07-30 |
| AP3777A (fr) | 2016-08-31 |
| EP2731603A1 (fr) | 2014-05-21 |
| AU2012282077A1 (en) | 2014-01-30 |
| JP2014522856A (ja) | 2014-09-08 |
| AP2014007413A0 (en) | 2014-02-28 |
| WO2013008218A1 (fr) | 2013-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1122853T1 (el) | Σταθερα σκευασματα λινακλοτιδης | |
| CY1121150T1 (el) | Νευροδραστικα 19-αλκοξυ-17-υποκατεστημενα στεροειδη, χρησιμα σε μεθοδους θεραπειας | |
| EA201891103A1 (ru) | Композиции для лечения спинальной мышечной атрофии | |
| EA202090486A3 (ru) | Соединения для лечения спинальной мышечной атрофии | |
| CY1118379T1 (el) | Αναστολεις ιου ηπατιτιδας c | |
| EA201300989A1 (ru) | Водная фармацевтическая композиция тапентадола для перорального введения | |
| EA201390766A1 (ru) | БЕНЗОКСАЗЕПИНЫ КАК ИНГИБИТОРЫ PI3K/mTOR И СПОСОБЫ ИХ ИСПОЛЬЗОВАНИЯ И ПОЛУЧЕНИЯ | |
| EA202190619A1 (ru) | Противовирусные соединения | |
| EA201591166A1 (ru) | Ингибиторы аутотаксина | |
| EA201391087A1 (ru) | Оральные лекарственные формы препарата тазоцитиниба с модифицированным высвобождением | |
| UA109010C2 (en) | MORPHOLINOPYRIMIDINES AND THEIR APPLICATIONS IN THERAPY | |
| EA201491672A1 (ru) | Гетероциклильные соединения как ингибиторы mek | |
| EA201391029A1 (ru) | Производные оксазина и их применение при лечении неврологических нарушений | |
| EA201590371A1 (ru) | 1,4-дизамещенные аналоги пиридазина и способы лечения связанных с дефицитом smn состояний | |
| EA201591195A1 (ru) | Новые хинолоновые производные | |
| EA201070597A1 (ru) | Антибактериальные аналоги аминогликозида | |
| EA201500298A1 (ru) | Алкоксипиразолы в качестве активаторов растворимой гуанилатциклазы | |
| EA201490471A1 (ru) | Пиридазиноновые соединения и их применение в качестве ингибиторов daao | |
| EA201600337A1 (ru) | 2,6-замещенные пуриновые производные и их применение в лечении пролиферативных заболеваний | |
| EA201301019A1 (ru) | Бензодиоксановые ингибиторы продуцирования лейкотриена | |
| EA201270741A1 (ru) | Пероральные композиции и липофильные соли метилналтрексона | |
| EA201691216A1 (ru) | Композиции линаклотида с замедленным высвобождением | |
| EA201370166A1 (ru) | Содержащие диарилацетиленгидразид ингибиторы тирозинкиназы | |
| EA201400976A1 (ru) | Бензодиоксаны в комбинации с другими активными средствами для ингибирования продуцирования лейкотриена | |
| EA201300034A1 (ru) | Фармацевтические композиции, содержащие иматиниб или его фармацевтически приемлемую соль, и способы их получения |